## SocIETy 

## CSR Activities Related to the Society 

## Basic Policy 

Astellas is working to enhance the sustainability of the society through its social contribution activities, including providing support to local communities and the advancement of medicine. We are also leveraging partnerships with a range of stakeholders in an effort to solve social issues which affect people throughout the world. 

## Material CSR Issues 

Improvement of healthcare infrastructure and service to solve Access to Health issues 

Patient assistance and advocacy 

## Review of Fiscal 2013 Initiatives 

Philanthropic community contribution 

Societal benefit-driven product development 

Advancement of medical science 

• Promoted joint drug discovery research on neglected tropical diseases (NTDs). Developed the world's first integrated NTDs drug discovery database called iNTRODB. 

• Developed an oral dispersible pediatric formulation of praziquantel for schistosomiasis. 

• Decided to support “Action on Fistula” program for treating obstetric fistula in Kenya (May 2014) 

• Pursued patient assistance and advocacy activities 

• Implemented “Changing Tomorrow Day” activities, an initiative for employees to participate in volunteer work 

• Implemented skills development training for research fellows from developing countries 

• Supported research that contributes to the advancement of medicine 

## Activities to be Tackled in Fiscal 2014 

Astellas will work to improve measures and provide disclosure of information with respect to social contribution activities such as donations, community contribution, and support for patients associations. In addition, Astellas will explore measures and leverage its strengths and technologies in addressing global social issues where it can contrib- ute as a pharmaceuticals company, including the Post-2015 Development Agenda. 

